Series C funding round for ImmunOs Therapeutics raising $11M in September 2024
Series C funding round for ImmunOs Therapeutics raising $11M in September 2024
| Investor | Firm Type | Partner |
|---|
GIMVLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Balaji Srinivasan |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$99.3M
Top Valuation
-
ImmunOs Therapeutics raised $11M in a Series C round.
The round was announced on 09/01/24.
The round was led by Gimv, Mission BioCapital.